Pharmathen Global Holding

Pharmathen is a leading European pharmaceutical company specializing in the development and manufacturing of complex generic products with a focus on advanced drug delivery technologies. The company is globally recognized for its expertise in Long-Acting Injectables (LAI), sustained-release formulations, and preservative-free ophthalmic products. Operating primarily through a B2B model, Pharmathen provides end-to-end R&D and manufacturing services to major pharmaceutical partners worldwide. Its robust portfolio includes over 100 products targeting high-barrier therapeutic areas such as oncology, central nervous system disorders, and ophthalmology. With state-of-the-art manufacturing facilities in Greece and a strong commitment to innovation, Pharmathen remains a critical player in the global supply of complex medicines.